Default company panoramic image
Logo

Regenome

Regeome produces a stem cell derived skin therapy in the form of a topical rejuvenation cream.

  • Stage Concept Only
  • Industry Biotechnology
  • Location San Francisco, CA, USA
  • Currency USD

Company Summary

We produce a raw ingredient consisting of skin rejuvenating stem cell molecules (not live cells). Our product is capable of achieving comparable results to clinical procedures, but with no pain, inconvenience, invasiveness, or need of certified professionals. Our customers are cosmetics companies wishing to provide their consumers with a next-generation topical cream capable of achieving efficacy results comparable to clinical procedures.

Team

  • Default avatar
    Ilya Tokhner
    CEO

    Previous work experience and education: Head of Business Development, Bina Technologies, a Stanford spin-off venture, International Sales, Boeing, Operations & Business Development, C.H. Robinson Worldwide, MBA, Vanderbilt, B.S., Magna Cum Laude, CSULB

  • Default avatar
    Mahni Ghorashi
    CMO

    Previous work experience and education: Founding Member, Trapit, a Stanford Research Institute (SRI) spin-off venture, Director of Business Development, LiteScape Technologies, MBA, Vanderbilt, Ph.D. candidate, Yale University, B.S., MIT

  • Default avatar
    Jordan Plews
    CSO

    Previous work experience and education: Post-Doctoral Fellow, Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Researcher, Bioprocess Development Group, Pfizer Ltd., Ph.D., Stem Cell Biology and Somatic Cell Reprogramming, University College London, BEng, Biochemical Engineering (1st class honors), University College London